In vitro antimicrobial and anticancer potential of hinokitiol against oral pathogens and oral cancer cell lines

Microbiological Research

Volumn 168, Issue 5, 2013, Pages 254-262

  Shih, Yin Hua ^a   Chang, Kuo Wei ^a,b   Hsia, Shih Min ^c   Yu, Cheng Chia ^d   Fuh, Lih Jyh ^e   Chi, Tzu Yun ^f   Shieh, Tzong Ming ^f  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Autolysin; Hinokitiol; Minimal inhibitory concentrations; Minimal microbicidal concentration; Oral squamous cell carcinoma; Paradoxical inhibition phenomenon (PIP)

Indexed keywords

AUTOLYSIN; HINOKITIOL; MINIMAL INHIBITORY CONCENTRATION; ORAL SQUAMOUS CELL CARCINOMATA; PARADOXICAL INHIBITION PHENOMENON (PIP);

CANDIDA; CELL CULTURE; HEALTH CARE; MICROORGANISMS;

CYTOTOXICITY;

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; BETA-THUJAPLICIN; DRUG DERIVATIVE; TERPENE; THUJAPLICIN; TROPOLONE;

AGAR; ANTIMICROBIAL ACTIVITY; BACTERIUM; CANCER; CONCENTRATION (COMPOSITION); CONIFEROUS TREE; DISEASE TREATMENT; GROWTH RATE; INHIBITION; INHIBITOR; ORAL HEALTH; PLANT EXTRACT;

ARTICLE; BACTERIUM; CANDIDA ALBICANS; CELL SURVIVAL; DRUG EFFECT; DRUG SCREENING; HUMAN; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; TUMOR CELL LINE;

ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; BACTERIA; CANDIDA ALBICANS; CELL LINE, TUMOR; CELL SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MONOTERPENES; TROPOLONE;

CANDIDA ALBICANS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS MUTANS;

EID: 84876407891     PISSN: 09445013     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micres.2012.12.007     Document Type: Article

References (32)

1. Arima Y., Nakai Y., Hayakawa R., Nishino T. Antibacterial effect of beta-thujaplicin on staphylococci isolated from atopic dermatitis: relationship between changes in the number of viable bacterial cells and clinical improvement in an eczematous lesion of atopic dermatitis. J Antimicrob Chemother 2003, 51(1):113-122.
2. Blackman S.A., Smith T.J., Foster S.J. The role of autolysins during vegetative growth of Bacillus subtilis 168. Microbiology 1998, 144(Pt 1):73-82.
3. Brown A.J., Gow N.A. Regulatory networks controlling Candida albicans morphogenesis. Trends Microbiol 1999, 7(8):333-338.
4. Chisty M.M., Nargis M., Inaba T., Ishita K., Osanai A., Kamiya H. Transmission electron microscopy of Schistosoma mansoni cercariae treated with hinokitiol (beta-thujaplicin), a compound for potential skin application against cercarial penetration. Tohoku J Exp Med 2004, 202(1):63-67.
5. Eagle H. A paradoxical zone phenomenon in the bactericidal action of penicillin in vitro. Science 1948, 107(2767):44-45.
6. Ema M., Harazono A., Fujii S., Kawashima K. Evaluation of developmental toxicity of beta-thujaplicin (hinokitiol) following oral administration during organogenesis in rats. Food Chem Toxicol 2004, 42(3):465-470.
7. Fontana R., Boaretti M., Grossato A., Tonin E.A., Lleo M.M., Satta G. Paradoxical response of Enterococcus faecalis to the bactericidal activity of penicillin is associated with reduced activity of one autolysin. Antimicrob Agents Chemother 1990, 34(2):314-320.
8. Gilbard J.P., Douyon Y., Huson R.B. Time-kill assay results for a linalool-hinokitiol-based eyelid cleanser for lid hygiene. Cornea 2010, 29(5):559-563.
9. Higashi Y., Sakata M., Fujii Y. High-performance liquid chromatography with dual-wavelength ultraviolet detection for measurement of hinokitiol in personal care products. J Cosmet Sci 2009, 60(5):519-525.
10. Holbrook W.P., Kippax R. Sensitivity of Candida albicans from patients with chronic oral candidiasis. Postgrad Med J 1979, 55(647):692-694.
11. Holowachuk S.A., Bal'a M.F., Buddington R.K. A kinetic microplate method for quantifying the antibacterial properties of biological fluids. J Microbiol Methods 2003, 55(2):441-446.
12. Ido Y., Muto N., Inada A., Kohroki J., Mano M., Odani T., et al. Induction of apoptosis by hinokitiol, a potent iron chelator, in teratocarcinoma F9 cells is mediated through the activation of caspase-3. Cell Prolif 1999, 32(1):63-73.
13. Imai N., Doi Y., Nabae K., Tamano S., Hagiwara A., Kawabe M., et al. Lack of hinokitiol (beta-thujaplicin) carcinogenicity in F344/DuCrj rats. J Toxicol Sci 2006, 31(4):357-370.
14. Inamori Y., Sakagami Y., Morita Y., Shibata M., Sugiura M., Kumeda Y., et al. Antifungal activity of Hinokitiol-related compounds on wood-rotting fungi and their insecticidal activities. Biol Pharm Bull 2000, 23(8):995-997.
15. Komaki N., Watanabe T., Ogasawara A., Sato N., Mikami T., Matsumoto T. Antifungal mechanism of hinokitiol against Candida albicans. Biol Pharm Bull 2008, 31(4):735-737.
16. Krenn B.M., Gaudernak E., Holzer B., Lanke K., Van Kuppeveld F.J., Seipelt J. Antiviral activity of the zinc ionophores pyrithione and hinokitiol against picornavirus infections. J Virol 2009, 83(1):58-64.
17. Liu S., Yamauchi H. Hinokitiol, a metal chelator derived from natural plants, suppresses cell growth and disrupts androgen receptor signaling in prostate carcinoma cell lines. Biochem Biophys Res Commun 2006, 351(1):26-32.
18. Meurman J.H., Jousimies-Somer H., Suomala P., Alaluusua S., Torkko H., Asikainen S. Activity of amine-stannous fluoride combination and chlorhexidine against some aerobic and anaerobic oral bacteria. Oral Microbiol Immunol 1989, 4(2):117-119.
19. Mitchell L.S., Tuomanen E.I. Molecular analysis of antibiotic tolerance in pneumococci. Int J Med Microbiol IJMM 2002, 292(2):75-79.
20. Miyake M., Ohbayashi Y., Iwasaki A., Ogawa T., Nagahata S. Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) and use of a nasal mupirocin ointment in oral cancer inpatients. Int J Oral Maxillofac Surg: Off J Am Assoc Oral Maxillofac Surg 2007, 65(11):2159-2163.
21. Miyamoto D., Kusagaya Y., Endo N., Sometani A., Takeo S., Suzuki T., et al. Thujaplicin-copper chelates inhibit replication of human influenza viruses. Antiviral Res 1998, 39(2):89-100.
22. Mohapatra D.P., Thakur V., Brar S.K. Antibacterial efficacy of raw and processed honey. Biotechnol Res Int 2011, 2011:917505.
23. Morita Y., Sakagami Y., Okabe T., Ohe T., Inamori Y., Ishida N. The mechanism of the bactericidal activity of hinokitiol. Biocontrol Sci 2007, 12(3):101-110.
24. Nagao Y., Sata M. Effect of oral care gel on the quality of life for oral lichen planus in patients with chronic HCV infection. Virol J 2011, 8:348.
25. Rice K.C., Bayles K.W. Death's toolbox: examining the molecular components of bacterial programmed cell death. Mol Microbiol 2003, 50(3):729-738.
26. Sheng W.H., Wang J.T., Lauderdale T.L., Weng C.M., Chen D., Chang S.C. Epidemiology and susceptibilities of methicillin-resistant Staphylococcus aureus in Taiwan: emphasis on chlorhexidine susceptibility. Diagn Microbiol Infect Dis 2009, 63(3):309-313.
27. Shieh T.M., Chang K.W., Tu H.F., Shih Y.H., Ko S.Y., Chen Y.C., et al. Association between the polymorphisms in exon 12 of hypoxia-inducible factor-1alpha and the clinicopathological features of oral squamous cell carcinoma. Oral Oncol 2010, 46(9):e47-e53.
28. Shih Y.H., Chang K.W., Chen M.Y., Yu C.C., Lin D.J., Hsia S.M., et al. Lysyl oxidase and enhancement of cell proliferation and angiogenesis in oral squamous cell carcinoma. Head Neck 2012, [Epub ahead of print]. 10.1002/hed.22959.
29. Stevens D.A., Espiritu M., Parmar R. Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations. Antimicrob Agents Chemother 2004, 48(9):3407-3411.
30. Tanaka T., Satoh T., Onozawa Y., Kohroki J., Itoh N., Ishidate M., et al. Apoptosis during iron chelator-induced differentiation in F9 embryonal carcinoma cells. Cell Biol Int 1999, 23(8):541-550.
31. Young K. In vitro antibacterial resistance selection and quantitation. Curr Protoc Pharmacol 2006, Chapter 13: Unit 13A 6.
32. Zoll S., Patzold B., Schlag M., Gotz F., Kalbacher H., Stehle T. Structural basis of cell wall cleavage by a staphylococcal autolysin. PLoS Pathogens 2010, 6(3):e1000807.